Qing Xu

6.2k total citations · 4 hit papers
182 papers, 4.3k citations indexed

About

Qing Xu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qing Xu has authored 182 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Oncology, 58 papers in Molecular Biology and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qing Xu's work include Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (11 papers) and Immunotherapy and Immune Responses (11 papers). Qing Xu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (11 papers) and Immunotherapy and Immune Responses (11 papers). Qing Xu collaborates with scholars based in China, United States and South Korea. Qing Xu's co-authors include Min Yuan, Jie Wu, Jianhua Chen, Lili Huang, Juemin Fang, Ran Cui, Zhuqing Liu, Xianling Guo, Hua Yu and Jin Cheng and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Qing Xu

169 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The emerging treatment landscape of targeted therapy in non-small-cell lung cancer

2019 490 citations Qing Xu et al. profile →
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways

2005 489 citations Qing Xu, Hua Yu et al. profile →
Wnt/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer

2022 298 citations Qing Xu et al. profile →
Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer

2021 195 citations Xianling Guo, Juemin Fang et al. profile →

Peers

Countries citing papers authored by Qing Xu

Since Specialization

Citations

This map shows the geographic impact of Qing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Xu more than expected).

Fields of papers citing papers by Qing Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Xu. The network helps show where Qing Xu may publish in the future.

Co-authorship network of co-authors of Qing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Xu. A scholar is included among the top collaborators of Qing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Xu. Qing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	p23 protects against ferroptosis of brain microvascular endothelial cells in ischemic stroke 2025 ·International Journal of Molecular Medicine ·Yao Zhao, Yunfei Xu, Qing Xu, (unknown), Jie Zhao, Ying Liu	3
2	A Mobile Applet for Assessing Medication Adherence and Managing Adverse Drug Reactions Among Patients With Cancer: Usability and Utility Study 2024 ·JMIR Formative Research ·Chenxu Ni, (unknown), (unknown), (unknown), Qing Xu, Fu‐Ming Shen, Dongjie Li, Fang Huang	2
3	Low-Temperature Cross-Linkable Hole Transport Material Based on Carbazole Derivatives Design and Applications in Solution-Processed OLEDs 2024 ·Macromolecules ·Zhou Zhou, (unknown), (unknown), (unknown), Zheng Huang, Pengxiang Wang, Qing Xu, Shanghui Ye, (unknown), (unknown), Wen‐Yong Lai	2
4	BRIX1 promotes ribosome synthesis and enhances glycolysis by selected translation of GLUT1 in colorectal cancer 2024 ·The Journal of Gene Medicine ·Chunhui Jiang, Longci Sun, (unknown), Yuan Tian, Chunjie Xu, Qing Xu, Hanbing Xue	6
5	A Prostatic Intraepithelial Neoplasia-Dependent p27Kip1 Checkpoint Induces Senescence and Inhibits Cell Proliferation and Cancer Progression 2024 ·Cancer Cell ·Pradip K. Majumder, Chiara Grisanzio, Fionnuala O’Connell, Marc Barry, Joseph Brito, Qing Xu, Isil Guney, Raanan Berger, Paula Herman, Rachel Bikoff, Giuseppe Fedele, Won‐Ki Baek, Shunyou Wang, Katharine Ellwood‐Yen, Hong Wu, Charles Sawyers, Sabina Signoretti, William C. Hahn, Massimo Loda, William R. Sellers	0
6	RNA helicase DHX9 enables PBX1 mRNA translation by unfolding RNA G-quadruplex in melanoma 2024 ·SHILAP Revista de lepidopterología ·Yuan Sui, Qing Xu, Daniel Liu, Jing Liu	1
7	Finger–coding intelligent human–machine interaction system based on all–fabric ionic capacitive pressure sensors 2023 ·Nano Energy ·Qingzhou Wang, Yuanyue Li, Qing Xu, (unknown), (unknown), Qihui Zhou, Rajendra Dhakal, Yang Li, Zhao Yao	54
8	Enhanced sensitivity and detection range of a flexible pressure sensor utilizing a nano-cracked PVP hierarchical nanofiber membrane formed by BiI3 sublimation 2023 ·Chemical Engineering Journal ·(unknown), (unknown), Qingzhou Wang, (unknown), Eun‐Seong Kim, Qing Xu, Ho‐Kun Sung, Zhao Yao, Yuanyue Li, Nam‐Young Kim	32
9	Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study 2023 ·BMC Cancer ·Chuanliang Cui, Yu Chen, Zhiguo Luo, Zhengyun Zou, Yu Jiang, Hongming Pan, Qingxia Fan, (unknown), Qing Xu, (unknown), Xuan Wang, (unknown), Zhen Guo, Lu Si, Zhihong Chi, Xinan Sheng, (unknown), Qian Tan, Di Wu, Jun Guo	6
10	Discovery and Evaluation of 3-Quinoxalin Urea Derivatives as Potent, Selective, and Orally Available ATM Inhibitors Combined with Chemotherapy for the Treatment of Cancer via Goal-Oriented Molecule Generation and Virtual Screening 2023 ·Journal of Medicinal Chemistry ·(unknown), Yingxue Yang, Yurong Zou, (unknown), Chufeng Zhang, Minghai Tang, Tao Yang, Yong Chen, (unknown), (unknown), Shunjie Zhang, (unknown), (unknown), Qing Xu, Wen He, Dingguo Xu, (unknown), Lijuan Chen	14
11	Molecular chaperones in stroke-induced immunosuppression 2023 ·Neural Regeneration Research ·(unknown), Qing Xu, (unknown), (unknown), (unknown), Jie Tang, Jie Zhao, Ying Liu	9
12	Oncolytic adenovirus H101 ameliorate the efficacy of anti‐PD‐1 monotherapy in colorectal cancer 2022 ·Cancer Medicine ·Lili Huang, (unknown), (unknown), Hong Chen, Bin Xu, (unknown), Yu Zhao, Zhuqing Liu, (unknown), Qing Xu	15
13	Low temperature scintillation performance of a Br-doped CH₃NH₃PbCl₃ single-crystalline perovskite 2021 ·RSC Advances ·Jun Liu, (unknown), Qiang Xu, (unknown), Jinlu Ruan, Xiaoping Ouyang, Jing Nie, (unknown), Qing Xu, Bin Sun	7
14	Targeting STAT3 enhances NDV‐induced immunogenic cell death in prostate cancer cells 2020 ·Journal of Cellular and Molecular Medicine ·(unknown), Xiaoyan Shao, (unknown), Ke Jiang, (unknown), Jianhua Chen, Juemin Fang, Xianling Guo, Min Yuan, Ji Shi, Chan Ding, Songshu Meng, Qing Xu	36
15	Human macrophages survive and adopt activated genotypes in living zebrafish 2019 ·Scientific Reports ·Colin D. Paul, (unknown), Kevin Bishop, Qing Xu, William J. Wulftange, (unknown), (unknown), (unknown), Daniel S. Green, Jack R. Staunton, Swati Choksi, Zheng-gang Liu, Raman Sood, Kandice Tanner	17
16	The Traditional Chinese Medicinal Formula BDL301 Suppresses Tumor Growth by Inhibiting STAT3 Pathway and Inducing Apoptosis in Colorectal Cancer Cells 2015 ·DNA and Cell Biology ·Li Chu, (unknown), Juemin Fang, Chunyan Li, Zhuqing Liu, Ran Cui, Fei Hu, Xi Zhang, (unknown), Hui Han, Chuanhai Cao, Qing Xu	9
17	Double-blinded, Controlled, Randomized Study of Dihydrocodeine Tartrate vs Codeine Phosphate in Treating Cancer Pain 2005 ·The Chinese-German Journal of Clinical Oncology ·Jie Wang, Jianjun Zou, Yong Gao, Qing Xu, (unknown), Jianxin Qian, Defeng Xu, (unknown)	1
18	Chinese Herbal Formula, Bing De Ling, Enhances Antitumor Effects and Ameliorates Weight Loss Induced by 5-Fluorouracil in the Mouse CT26 Tumor Model 2005 ·DNA and Cell Biology ·Qing Xu, Jeffrey G. Brabham, Shumin Zhang, Pamela N. Münster, Karen K. Fields, (unknown), Hua Yu	6
19	[Preparation of senkyunolide I by reversed-phase high performance liquid chromatography]. 2004 ·MPG.PuRe (Max Planck Society) ·Xiaozhe Zhang, Qing Xu, Hongbin Xiao, Xinmiao Liang	2
20	Comparison between acclimated and unacclimated biomass affecting anaerobic–aerobic transformations in the biological removal of phosphorus 2004 ·Process Biochemistry ·Yinguang Chen, (unknown), (unknown), Qing Xu, Qi Zhou, Guowei Gu	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact